Anti-VEGF (vascular endothelial growth factor) drugs are a class of medications used to treat various eye diseases, including age-related macular degeneration (AMD), diabetic retinopathy, and macular edema. They work by blocking the action of VEGF, which is a protein that stimulates the growth of new blood vessels in the retina.
These drugs are typically administered via injection into the eye and can help improve vision, reduce swelling and inflammation, and prevent further damage to the retina. Some common anti-VEGF drugs include Avastin, Lucentis, and Eylea.
While these drugs can be effective in treating eye diseases, they do come with potential side effects. Some patients may experience eye pain, blurred vision, sensitivity to light, or infection. Additionally, long-term use of these drugs may increase the risk of other eye conditions such as glaucoma or cataracts.
Overall, anti-VEGF therapy can be an effective treatment option for certain eye diseases and can help improve vision and prevent further complications. However, it is important to discuss the potential benefits and risks with a healthcare provider before starting any treatment.
Ne Demek sitesindeki bilgiler kullanıcılar vasıtasıyla veya otomatik oluşturulmuştur. Buradaki bilgilerin doğru olduğu garanti edilmez. Düzeltilmesi gereken bilgi olduğunu düşünüyorsanız bizimle iletişime geçiniz. Her türlü görüş, destek ve önerileriniz için iletisim@nedemek.page